Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 0.0 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
How concentrated it has been
31 priced months, Feb 2024 to Sep 2026 · at each month’s NSE closes
Top 10 holdings, share of equity
75.8% now, 76.7% in Sep 2025 · highest 82.9%, lowest 75.8%
Companies held
20 now, 20 in Sep 2025 · largest single holding 17.0% of equity
How it trades: no clear lean toward recent winners or losers (score +0.00 over 25 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- DSP Nifty Healthcare Index FundDSP · 20 shared100.0%
- ICICI Prudential Nifty Healthcare ETFICICI Prudential · 20 shared100.0%
- Axis NIFTY Healthcare ETFAxis · 20 shared100.0%
- ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETFAditya Birla Sun Life · 20 shared99.9%
- EODWHFEdelweiss · 18 shared91.8%
- Nippon India Nifty Pharma ETFNippon India · 16 shared81.1%
- ICICI Prudential Nifty Pharma Index FundICICI Prudential · 16 shared81.1%
- Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 20 shared79.8%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
Complete exits
Largest increases
- None this month.
Largest reductions
- 01 Biocon Limited-5.5% -612
- 02 Sun Pharmaceutical Industries Limited-3.3% -543
- 03 Max Healthcare Institute Limited-3.3% -380
- 04 Dr. Reddy's Laboratories Limited-3.2% -306
- 05 Cipla Limited-3.3% -287
- 06 Fortis Healthcare Limited-3.3% -266
- 07 Laurus Labs Limited-3.2% -193
- 08 Zydus Lifesciences Limited-4.2% -162
- 09 Aurobindo Pharma Limited-3.4% -148
- 10 Lupin Limited-3.3% -123
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 17.00% | 2.90 Cr | 15,953 | by Feb 2024 (31 mo+) |
| Divi's Laboratories Limited | Healthcare | Large Cap | 10.44% | 1.78 Cr | 1,915 | by Feb 2024 (31 mo+) |
| Apollo Hospitals Enterprise Limited | Healthcare | Large Cap | 7.43% | 1.27 Cr | 1,551 | by Feb 2024 (31 mo+) |
| Laurus Labs Limited | Healthcare | Mid Cap | 6.82% | 1.16 Cr | 5,868 | by Feb 2024 (31 mo+) |
| Cipla Limited | Healthcare | Large Cap | 6.70% | 1.14 Cr | 8,479 | by Feb 2024 (31 mo+) |
| Dr. Reddy's Laboratories Limited | Healthcare | Large Cap | 6.65% | 1.13 Cr | 9,189 | by Feb 2024 (31 mo+) |
| Torrent Pharmaceuticals Limited | Healthcare | Large Cap | 6.24% | 1.06 Cr | 2,217 | by Feb 2024 (31 mo+) |
| Max Healthcare Institute Limited | Healthcare | Large Cap | 6.12% | 1.04 Cr | 11,213 | by Feb 2024 (31 mo+) |
| Lupin Limited | Healthcare | Mid Cap | 4.36% | 0.74 Cr | 3,660 | by Feb 2024 (31 mo+) |
| Aurobindo Pharma Limited | Healthcare | Mid Cap | 4.08% | 0.70 Cr | 4,164 | by Feb 2024 (31 mo+) |
| Fortis Healthcare Limited | Healthcare | Mid Cap | 3.55% | 0.60 Cr | 7,851 | Mar 2025 (19 mo) |
| Glenmark Pharmaceuticals Limited | Healthcare | Mid Cap | 3.11% | 0.53 Cr | 2,269 | by Feb 2024 (31 mo+) |
| Alkem Laboratories Limited | Healthcare | Mid Cap | 2.75% | 0.47 Cr | 909 | by Feb 2024 (31 mo+) |
| Zydus Lifesciences Limited | Healthcare | Mid Cap | 2.55% | 0.43 Cr | 3,734 | by Feb 2024 (31 mo+) |
| Mankind Pharma Limited | Healthcare | Mid Cap | 2.51% | 0.43 Cr | 1,707 | Mar 2025 (19 mo) |
| IPCA Laboratories Limited | Healthcare | Mid Cap | 2.37% | 0.40 Cr | 2,093 | by Feb 2024 (31 mo+) |
| Biocon Limited | Healthcare | Mid Cap | 2.28% | 0.39 Cr | 10,501 | by Feb 2024 (31 mo+) |
| Gland Pharma Limited | Healthcare | Small Cap | 2.04% | 0.35 Cr | 1,201 | Sep 2026 (1 mo) |
| Krishna Institute of Medical Sciences Limited | Healthcare | Small Cap | 1.76% | 0.30 Cr | 4,021 | Sep 2026 (1 mo) |
| Abbott India Limited | Healthcare | Mid Cap | 1.26% | 0.21 Cr | 79 | by Feb 2024 (31 mo+) |
Half of its current holdings have been held for 31 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Piramal Pharma Limited | Sep 2026 | ▼ Complete exit | -9,689 |
| Krishna Institute of Medical Sciences Limited | Sep 2026 | ▲ New position | +4,021 |
| Syngene International Limited | Sep 2026 | ▼ Complete exit | -2,960 |
| Gland Pharma Limited | Sep 2026 | ▲ New position | +1,201 |
| Biocon Limited | Sep 2026 | ▼ Reducing | -612 |
| Sun Pharmaceutical Industries Limited | Sep 2026 | ▼ Reducing | -543 |
| Max Healthcare Institute Limited | Sep 2026 | ▼ Reducing | -380 |
| Dr. Reddy's Laboratories Limited | Sep 2026 | ▼ Reducing | -306 |
| Cipla Limited | Sep 2026 | ▼ Reducing | -287 |
| Fortis Healthcare Limited | Sep 2026 | ▼ Reducing | -266 |
| Laurus Labs Limited | Sep 2026 | ▼ Reducing | -193 |
| Zydus Lifesciences Limited | Sep 2026 | ▼ Reducing | -162 |
| Aurobindo Pharma Limited | Sep 2026 | ▼ Reducing | -148 |
| Lupin Limited | Sep 2026 | ▼ Reducing | -123 |
| Glenmark Pharmaceuticals Limited | Sep 2026 | ▼ Reducing | -76 |
| IPCA Laboratories Limited | Sep 2026 | ▼ Reducing | -71 |
| Torrent Pharmaceuticals Limited | Sep 2026 | ▼ Reducing | -68 |
| Divi's Laboratories Limited | Sep 2026 | ▼ Reducing | -64 |
| Mankind Pharma Limited | Sep 2026 | ▼ Reducing | -56 |
| Apollo Hospitals Enterprise Limited | Sep 2026 | ▼ Reducing | -52 |
| Abbott India Limited | Sep 2026 | ▼ Reducing | -3 |
| Alkem Laboratories Limited | Sep 2026 | ▼ Reducing | -2 |
| Sun Pharmaceutical Industries Limited | Aug 2026 | ▼ Reducing | -156 |
| Max Healthcare Institute Limited | Aug 2026 | ▼ Reducing | -111 |
| Biocon Limited | Aug 2026 | ▼ Reducing | -106 |
| Piramal Pharma Limited | Aug 2026 | ▼ Reducing | -92 |
| Dr. Reddy's Laboratories Limited | Aug 2026 | ▼ Reducing | -91 |
| Cipla Limited | Aug 2026 | ▼ Reducing | -83 |
| Fortis Healthcare Limited | Aug 2026 | ▼ Reducing | -78 |
| Laurus Labs Limited | Aug 2026 | ▼ Reducing | -58 |
| Aurobindo Pharma Limited | Aug 2026 | ▼ Reducing | -41 |
| Zydus Lifesciences Limited | Aug 2026 | ▼ Reducing | -38 |
| Lupin Limited | Aug 2026 | ▼ Reducing | -36 |
| Syngene International Limited | Aug 2026 | ▼ Reducing | -29 |
| Glenmark Pharmaceuticals Limited | Aug 2026 | ▼ Reducing | -23 |
| Torrent Pharmaceuticals Limited | Aug 2026 | ▼ Reducing | -22 |
| IPCA Laboratories Limited | Aug 2026 | ▼ Reducing | -20 |
| Divi's Laboratories Limited | Aug 2026 | ▼ Reducing | -19 |
| Mankind Pharma Limited | Aug 2026 | ▼ Reducing | -17 |
| Apollo Hospitals Enterprise Limited | Aug 2026 | ▼ Reducing | -15 |
| Alkem Laboratories Limited | Aug 2026 | ▼ Reducing | -9 |
| Torrent Pharmaceuticals Limited | Jul 2026 | ▲ Increasing | +646 |
| Sun Pharmaceutical Industries Limited | Jul 2026 | ▼ Reducing | -111 |
| Max Healthcare Institute Limited | Jul 2026 | ▼ Reducing | -78 |
| Biocon Limited | Jul 2026 | ▼ Reducing | -75 |
| Piramal Pharma Limited | Jul 2026 | ▼ Reducing | -65 |
| Dr. Reddy's Laboratories Limited | Jul 2026 | ▼ Reducing | -64 |
| Cipla Limited | Jul 2026 | ▼ Reducing | -59 |
| Fortis Healthcare Limited | Jul 2026 | ▼ Reducing | -55 |
| Laurus Labs Limited | Jul 2026 | ▼ Reducing | -40 |
| Aurobindo Pharma Limited | Jul 2026 | ▼ Reducing | -29 |
| Zydus Lifesciences Limited | Jul 2026 | ▼ Reducing | -27 |
| Lupin Limited | Jul 2026 | ▼ Reducing | -25 |
| Syngene International Limited | Jul 2026 | ▼ Reducing | -21 |
| Glenmark Pharmaceuticals Limited | Jul 2026 | ▼ Reducing | -16 |
| IPCA Laboratories Limited | Jul 2026 | ▼ Reducing | -15 |
| Divi's Laboratories Limited | Jul 2026 | ▼ Reducing | -14 |
| Mankind Pharma Limited | Jul 2026 | ▼ Reducing | -12 |
| Apollo Hospitals Enterprise Limited | Jul 2026 | ▼ Reducing | -11 |
| Alkem Laboratories Limited | Jul 2026 | ▼ Reducing | -6 |
| Sun Pharmaceutical Industries Limited | Jun 2026 | ▲ Increasing | +1,518 |
| Max Healthcare Institute Limited | Jun 2026 | ▲ Increasing | +1,068 |
| Biocon Limited | Jun 2026 | ▲ Increasing | +1,017 |
| Piramal Pharma Limited | Jun 2026 | ▲ Increasing | +923 |
| Dr. Reddy's Laboratories Limited | Jun 2026 | ▲ Increasing | +876 |
| Cipla Limited | Jun 2026 | ▲ Increasing | +808 |
| Fortis Healthcare Limited | Jun 2026 | ▲ Increasing | +746 |
| Laurus Labs Limited | Jun 2026 | ▲ Increasing | +557 |
| Zydus Lifesciences Limited | Jun 2026 | ▲ Increasing | +358 |
| Aurobindo Pharma Limited | Jun 2026 | ▲ Increasing | +357 |
| Lupin Limited | Jun 2026 | ▲ Increasing | +352 |
| Syngene International Limited | Jun 2026 | ▲ Increasing | +276 |
| Glenmark Pharmaceuticals Limited | Jun 2026 | ▲ Increasing | +215 |
| IPCA Laboratories Limited | Jun 2026 | ▲ Increasing | +199 |
| Divi's Laboratories Limited | Jun 2026 | ▲ Increasing | +182 |
| Mankind Pharma Limited | Jun 2026 | ▲ Increasing | +162 |
| Torrent Pharmaceuticals Limited | Jun 2026 | ▲ Increasing | +155 |
| Apollo Hospitals Enterprise Limited | Jun 2026 | ▲ Increasing | +147 |
| Alkem Laboratories Limited | Jun 2026 | ▲ Increasing | +83 |
| Abbott India Limited | Jun 2026 | ▲ Increasing | +8 |
| Sun Pharmaceutical Industries Limited | May 2026 | ▲ Increasing | +948 |
| Max Healthcare Institute Limited | May 2026 | ▲ Increasing | +667 |
| Biocon Limited | May 2026 | ▲ Increasing | +637 |
| Piramal Pharma Limited | May 2026 | ▲ Increasing | +553 |
| Dr. Reddy's Laboratories Limited | May 2026 | ▲ Increasing | +545 |
| Cipla Limited | May 2026 | ▲ Increasing | +502 |
| Fortis Healthcare Limited | May 2026 | ▲ Increasing | +465 |
| Laurus Labs Limited | May 2026 | ▲ Increasing | +349 |
| Aurobindo Pharma Limited | May 2026 | ▲ Increasing | +249 |
| Zydus Lifesciences Limited | May 2026 | ▲ Increasing | +223 |
| Lupin Limited | May 2026 | ▲ Increasing | +216 |
| Syngene International Limited | May 2026 | ▲ Increasing | +168 |
| Glenmark Pharmaceuticals Limited | May 2026 | ▲ Increasing | +134 |
| IPCA Laboratories Limited | May 2026 | ▲ Increasing | +125 |
| Divi's Laboratories Limited | May 2026 | ▲ Increasing | +114 |
| Mankind Pharma Limited | May 2026 | ▲ Increasing | +101 |
| Torrent Pharmaceuticals Limited | May 2026 | ▲ Increasing | +93 |
| Apollo Hospitals Enterprise Limited | May 2026 | ▲ Increasing | +92 |
| Alkem Laboratories Limited | May 2026 | ▲ Increasing | +52 |
| Abbott India Limited | May 2026 | ▲ Increasing | +6 |
Changes compare consecutive month-end disclosures for this portfolio only.